Who is sponsoring NCT03393156?

NCT03393156 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT03393156?

Interventions in NCT03393156: Internet-based metacognitive therapy.

What condition does NCT03393156 study?

NCT03393156 studies Excessive Worry.

Is NCT03393156 still recruiting?

NCT03393156 is currently completed. Last updated 7 August 2018.

Last reviewed 2018-08-07 · How we verify

NCT03393156

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Negative Meta-cognitions as a Causal Factor to Worry

Completed NA Last updated 7 August 2018

What this trial tests

NA trial testing Internet-based metacognitive therapy in Excessive Worry in 108 participants. Completed in 6 May 2018.

Timeline

6 February 2018

Primary endpoint
6 May 2018

6 May 2018

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	108
Start date	6 February 2018
Primary completion	6 May 2018
Estimated completion	6 May 2018
Sites	1 location across Sweden

Drugs / interventions tested

Internet-based metacognitive therapy

Conditions studied

Excessive Worry — all drugs for Excessive Worry →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Excessive Worry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate if an internet-based metacognitive therapy reduces negative metacognitions and if reductions negative metacognitions mediates reductions in worry.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapist-guided online metacognitive intervention for excessive worry: a randomized controlled trial with mediation analysis.
Wahlund T, Hesser H, Perrin S, Johansson S, et al · · 2022 · cited 7× · PMID 34283004 · DOI 10.1080/16506073.2021.1937695

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393156 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 7 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing